LONDON, Nov 24 (Reuters) – Britain is to stop using GlaxoSmithKline’s cervical cancer vaccine Cervarix from next September and will instead offer girls Merck & Co’s rival product Gardasil.

UPDATE 3-UK switches to Merck’s Gardasil for HPV vaccination

HERE By Ben Hirschler Nov 24, 2011

The move underscores Gardasil’s lead in a $1 billion-plus worldwide market for vaccines that protect against the sexually transmitted human papillomavirus (HPV), which can cause cervical cancer.

Full report  HERE

HERE Gardasil is the HPV vaccine, touted to fight cervical cancer. What they are not telling you is that thousands of girls are having adverse reactions to the HPV Vaccines, some have even died -at last count, at least 103 lives have been lost. We have got to do something about this.

Posted on July 24th, 2009 HERE Gardasil contains genetically-engineered virus-like protein particles and aluminum, which affect the immune system. However, the vaccine’s mechanism of protection is unknown and it has not been evaluated for the potential to be carcinogenic nor tested for possible toxicity to the genes.

By the summer of 2009, Gardasil had already caused more than 15,000 thousand reports of adverse vaccine reactions, injuring more than 3,000 and killing 48, with 14 deaths claiming girls under the age of 16.

Video HERE